Simplex Trading, LLC Sangamo Therapeutics, Inc Transaction History
Simplex Trading, LLC
- $3.28 Billion
- Q4 2024
A detailed history of Simplex Trading, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 192,538 shares of SGMO stock, worth $219,493. This represents 0.01% of its overall portfolio holdings.
Number of Shares
192,538
Previous 114,736
67.81%
Holding current value
$219,493
Previous $98,000
100.0%
% of portfolio
0.01%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding SGMO
# of Institutions
113Shares Held
57.8MCall Options Held
576KPut Options Held
1.17M-
Wasatch Advisors Inc Salt Lake City, UT19.4MShares$22.2 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$10.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.85MShares$5.53 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$5.36 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.35MShares$2.68 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $178M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...